Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study

NCT03067974 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Initial results did not show benefit.

Conditions

Failed Moderate Sedation During Procedure
Ketamine Adverse Reaction

Interventions

DRUG: Ketamine Hcl 100Mg/Ml Inj

Sponsor

University of Arizona